000650 仁和药业
已收盘 05-29 15:00:00
资讯
新帖
简况
股市必读：仁和药业（000650）5月25日董秘有最新回复
证券之星 · 05-26
股市必读：仁和药业（000650）5月25日董秘有最新回复
仁和药业：2026年回购股份已达14,000,650股
证券之星 · 05-25
仁和药业：2026年回购股份已达14,000,650股
仁和药业：2026年回购股份已达14,000,650股
证券之星 · 05-25
仁和药业：2026年回购股份已达14,000,650股
仁和药业：截至2025年12月31日产生收益145.36万
证券之星 · 05-25
仁和药业：截至2025年12月31日产生收益145.36万
股市必读：仁和药业（000650）5月20日董秘有最新回复
证券之星 · 05-21
股市必读：仁和药业（000650）5月20日董秘有最新回复
仁和药业：公司与控股股东仁和集团在人员、资产、财务、机构和业务方面都是独立的
证券之星 · 05-20
仁和药业：公司与控股股东仁和集团在人员、资产、财务、机构和业务方面都是独立的
股市必读：仁和药业（000650）5月18日董秘有最新回复
证券之星 · 05-19
股市必读：仁和药业（000650）5月18日董秘有最新回复
仁和药业：目前公司有减肥药品的销售
证券之星 · 05-18
仁和药业：目前公司有减肥药品的销售
仁和药业：股东会审议通过后两个月内完成分红派息
证券之星 · 05-18
仁和药业：股东会审议通过后两个月内完成分红派息
仁和药业（000650）披露回购公司股份比例达到1%暨回购进展的公告，5月13日股价下跌0.35%
证券之星 · 05-13
仁和药业（000650）披露回购公司股份比例达到1%暨回购进展的公告，5月13日股价下跌0.35%
仁和药业：产品质量始终是品牌的立业之本
证券之星 · 05-13
仁和药业：产品质量始终是品牌的立业之本
股市必读：仁和药业（000650）5月8日披露最新机构调研信息
证券之星 · 05-11
股市必读：仁和药业（000650）5月8日披露最新机构调研信息
股市必读：仁和药业（000650）5月7日董秘有最新回复
证券之星 · 05-08
股市必读：仁和药业（000650）5月7日董秘有最新回复
每周股票复盘：仁和药业（000650）股东户数下降3.15%
证券之星 · 05-03
每周股票复盘：仁和药业（000650）股东户数下降3.15%
仁和药业（000650）披露以集中竞价交易方式回购股份的回购报告书，4月28日股价上涨2.88%
证券之星 · 04-28
仁和药业（000650）披露以集中竞价交易方式回购股份的回购报告书，4月28日股价上涨2.88%
图解仁和药业一季报：第一季度单季净利润同比下降14.57%
证券之星 · 04-27
图解仁和药业一季报：第一季度单季净利润同比下降14.57%
仁和药业：公司有自己生产和销售的益生菌类产品
证券之星 · 04-27
仁和药业：公司有自己生产和销售的益生菌类产品
仁和药业：公司2021年6月，与北京洛必德科技有限公司签订了增资协议，支付投资款人民币1000万元，持股比例1.5365%
证券之星 · 04-27
仁和药业：公司2021年6月，与北京洛必德科技有限公司签订了增资协议，支付投资款人民币1000万元，持股比例1.5365%
股市必读：仁和药业年报 - 第四季度单季净利润同比下降78.75%
证券之星 · 04-27
股市必读：仁和药业年报 - 第四季度单季净利润同比下降78.75%
仁和药业(000650)4月20日股东户数9.2万户，较上期减少3.15%
证券之星 · 04-24
仁和药业(000650)4月20日股东户数9.2万户，较上期减少3.15%
加载更多
公司概况
公司名称：
仁和药业股份有限公司
所属行业：
医药制造业
上市日期：
1996-12-10
主营业务：
仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是口服固体制剂、口服液体制剂、大容量注射剂、小容量注射剂、外用洗剂、搽剂、栓剂、软膏剂、健康相关产品。
发行价格：
6.26
{"stockData":{"symbol":"000650","market":"SZ","secType":"STK","nameCN":"仁和药业","latestPrice":5.35,"timestamp":1780038216000,"preClose":5.24,"halted":0,"volume":14415706,"delay":0,"changeRate":0.021,"floatShares":1331000000,"shares":1400000000,"eps":0.2638,"marketStatus":"已收盘","change":0.11,"latestTime":"05-29 15:00:00","open":5.27,"high":5.36,"low":5.25,"amount":76596900,"amplitude":0.021,"askPrice":5.35,"askSize":1770,"bidPrice":5.34,"bidSize":190,"shortable":0,"etf":0,"ttmEps":0.2638,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780277400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.24,"symbolType":"stock","openAndCloseTimeList":[[1780018200000,1780025400000],[1780030800000,1780038000000]],"highLimit":5.76,"lowLimit":4.72,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1399938234,"isCdr":false,"pbRate":1.14,"roa":"--","peRate":20.280516,"roe":"2.2%","epsLYR":0.28,"committee":-0.194171,"marketValue":7490000000,"turnoverRate":0.0108,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-06-01。","floatMarketCap":7123000000},"requestUrl":"/m/hq/s/000650","defaultTab":"news","newsList":[{"id":"2638552380","title":"股市必读：仁和药业（000650）5月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2638552380","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638552380?lang=zh_cn&edition=full","pubTime":"2026-05-26 02:49","pubTimestamp":1779734949,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，仁和药业报收于5.41元，上涨0.56%，换手率0.7%，成交量9.36万手，成交额5052.91万元。投资者： 你好，公司已经回购了多少股份董秘： 尊敬的投资者您好，公司于2026年5月13日披露，2026年回购股份已达14,000,650股。公司在2025年3月4日和12月1日，分别使用1000万进入公司证券账户，截至2025年12月31日，产生收益145.36万。依据公司2025年度审计报告，公司处置交易性金融资产取得的投资收益为156.9571万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600001881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","000650","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638558478","title":"仁和药业：2026年回购股份已达14,000,650股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638558478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638558478?lang=zh_cn&edition=full","pubTime":"2026-05-25 20:51","pubTimestamp":1779713472,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，公司已经回购了多少股份仁和药业回复：尊敬的投资者您好，公司于2026年5月13日披露，2026年回购股份已达14,000,650股。六月初，公司会根据规定披露回购进展公告，届时请查阅相关公告。谢谢！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500031794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638558493","title":"仁和药业：2026年回购股份已达14,000,650股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638558493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638558493?lang=zh_cn&edition=full","pubTime":"2026-05-25 20:51","pubTimestamp":1779713470,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：今天为止，公司回购了多少股份仁和药业回复：尊敬的投资者您好，公司于2026年5月13日披露，2026年回购股份已达14,000,650股。六月初，公司会根据规定披露回购进展公告，届时请查阅相关公告。谢谢！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500031792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638538720","title":"仁和药业：截至2025年12月31日产生收益145.36万","url":"https://stock-news.laohu8.com/highlight/detail?id=2638538720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638538720?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:15","pubTimestamp":1779693337,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，近期看到相关公众号报道公司去年有超6000万元闲置资金用于炒股，但仅实现约66万元左右的收益，该情况是否属实？仁和药业回复：尊敬的投资者您好，情况不属实。公司在2025年3月4日和12月1日，分别使用1000万进入公司证券账户，截至2025年12月31日，产生收益145.36万。依据公司2025年度审计报告，公司处置交易性金融资产取得的投资收益为156.9571万元。详细见公司2025年度审计报告第93页之注释47 投资收益。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500014999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637873577","title":"股市必读：仁和药业（000650）5月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2637873577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637873577?lang=zh_cn&edition=full","pubTime":"2026-05-21 04:23","pubTimestamp":1779308589,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，仁和药业报收于5.48元，下跌1.62%，换手率0.78%，成交量10.34万手，成交额5671.29万元。贵司更以“仁和集团的问题请您致电仁和集团”为由推诿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100005037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636924798","title":"仁和药业：公司与控股股东仁和集团在人员、资产、财务、机构和业务方面都是独立的","url":"https://stock-news.laohu8.com/highlight/detail?id=2636924798","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636924798?lang=zh_cn&edition=full","pubTime":"2026-05-20 11:36","pubTimestamp":1779248184,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业05月20日在投资者关系平台上答复投资者关心的问题。贵司更以“仁和集团的问题请您致电仁和集团”为由推诿。您的问题，仁和药业股份有限公司的证券部已向公司董事会反馈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000019079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636003858","title":"股市必读：仁和药业（000650）5月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636003858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636003858?lang=zh_cn&edition=full","pubTime":"2026-05-19 01:52","pubTimestamp":1779126733,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，仁和药业报收于5.52元，下跌0.9%，换手率0.91%，成交量12.07万手，成交额6659.83万元。董秘最新回复投资者： 董秘你好，感谢回复。系统显示的发送成功时间是：2026年5月13日17：44。董秘： 尊敬的投资者您好，公司每个部门都有其明确的职能，证券部不是全能部门，涉及正常商业咨询或投诉，请致电公司全国统一400客服号。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900002152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636023320","title":"仁和药业：目前公司有减肥药品的销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2636023320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636023320?lang=zh_cn&edition=full","pubTime":"2026-05-18 16:03","pubTimestamp":1779091391,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！世界医药巨头礼来和诺和诺德都非常看好最新的减肥加增肌的口服药，研究和开发费用惊人！请问，贵司有没有计划开发口服的减肥加增肌的新一代减肥药物吗？谢谢！仁和药业回复：尊敬的投资者您好，目前公司有减肥药品的销售。您提到的新一代减肥药物的研发，建议收到。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800020464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636046561","title":"仁和药业：股东会审议通过后两个月内完成分红派息","url":"https://stock-news.laohu8.com/highlight/detail?id=2636046561","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636046561?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:36","pubTimestamp":1779075370,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：你好。公司什么时候分红派息仁和药业回复：尊敬的投资者您好，根据工作安排，公司2025年度股东会计划于6月份召开，股东会审议通过后届时在两个月内完成分红派息工作。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800012757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0239","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635673309","title":"仁和药业（000650）披露回购公司股份比例达到1%暨回购进展的公告，5月13日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635673309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635673309?lang=zh_cn&edition=full","pubTime":"2026-05-13 22:30","pubTimestamp":1778682631,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，仁和药业报收于5.67元，较前一交易日下跌0.35%，最新总市值为79.38亿元。该股当日开盘5.68元，最高5.72元，最低5.65元，成交额达7254.13万元，换手率为0.96%。近日，仁和药业股份有限公司发布《关于回购公司股份比例达到1%暨回购进展的公告》。公告显示，公司于2026年4月22日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，拟使用自有资金8,000万至15,000万元回购股份，用于股权激励或员工持股计划，回购价格不超过8.00元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300045766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0239","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635275306","title":"仁和药业：产品质量始终是品牌的立业之本","url":"https://stock-news.laohu8.com/highlight/detail?id=2635275306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635275306?lang=zh_cn&edition=full","pubTime":"2026-05-13 11:37","pubTimestamp":1778643433,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！贵公司这次赞助江西足球赛事，打出了仁心仁爱，仁和药业横幅，证明公司对体育事业发展起到了积极推动作用，公司是不是打算打造百年仁和？是不是准备把品质和口碑做起来？仁和药业回复：尊敬的投资者您好，产品质量始终是品牌的立业之本，我们一直放在首位。感谢您对公司的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300017997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634442550","title":"股市必读：仁和药业（000650）5月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2634442550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634442550?lang=zh_cn&edition=full","pubTime":"2026-05-11 01:54","pubTimestamp":1778435653,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，仁和药业报收于5.71元，上涨0.35%，换手率0.96%，成交量12.84万手，成交额7333.44万元。中药经典名方二冬汤颗粒未参与2025年医保谈判，已有销售但利润贡献有限。二冬汤颗粒为公司首个获批的经典名方产品，具体获批时间依国家药监局审评进度而定。医药OTC行业处于2025年深度调整、2026年筑底企稳的过渡期。2026年一季度公司营收同比增长14.57%，扣非净利润增长33.20%，主因药品主业利润贡献上升，从上年同期1.02亿元增至1.36亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100000913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633173193","title":"股市必读：仁和药业（000650）5月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2633173193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633173193?lang=zh_cn&edition=full","pubTime":"2026-05-08 03:22","pubTimestamp":1778181732,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，仁和药业报收于5.69元，上涨0.0%，换手率1.09%，成交量14.53万手，成交额8267.24万元。关于参加江西辖区上市公司2026年投资者网上集体接待日活动的公告仁和药业股份有限公司将参加由江西省上市公司协会举办的2026年江西辖区上市公司投资者网上集体接待日活动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800003567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632608175","title":"每周股票复盘：仁和药业（000650）股东户数下降3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632608175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632608175?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:32","pubTimestamp":1777768331,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，仁和药业报收于5.69元，较上周的5.55元上涨2.52%。本周，仁和药业4月28日盘中最高价报5.78元。业绩披露要点：仁和药业2026年一季报显示，扣非净利润1.36亿元，同比上升33.2%。股本股东变化股东户数变动截至2026年4月20日，仁和药业股东户数为9.2万户，较3月31日减少2994.0户，减幅为3.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0239","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630068303","title":"仁和药业（000650）披露以集中竞价交易方式回购股份的回购报告书，4月28日股价上涨2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630068303","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630068303?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:23","pubTimestamp":1777375381,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，仁和药业报收于5.72元，较前一交易日上涨2.88%，最新总市值为80.08亿元。仁和药业于近日披露《公司关于以集中竞价交易方式回购股份的回购报告书》。公告显示，公司拟使用自有资金以集中竞价交易方式回购公司股份，回购资金总额不低于8,000.00万元且不超过15,000.00万元，回购价格不超过8.00元/股。本次回购股份拟用于后续实施股权激励或员工持股计划。预计回购股份数量约为1,000.00万股至1,875.00万股，占公司总股本比例0.71%至1.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800055308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630946367","title":"图解仁和药业一季报：第一季度单季净利润同比下降14.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630946367","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630946367?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:19","pubTimestamp":1777285188,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业2026年一季报显示，一季度公司主营收入11.29亿元，同比上升14.57%；归母净利润1.4亿元，同比下降14.57%；扣非净利润1.36亿元，同比上升33.2%；负债率10.38%，投资收益549.85万元，财务费用-53.8万元，毛利率36.7%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700034078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630657733","title":"仁和药业：公司有自己生产和销售的益生菌类产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2630657733","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630657733?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:21","pubTimestamp":1777278077,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问公司益生菌产品是自产还是代工？B420等菌株的销售情况如何？有没有瘦身减肥的功效？仁和药业回复：尊敬的投资者您好，公司有自己生产和销售的益生菌类产品。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700028841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630836510","title":"仁和药业：公司2021年6月，与北京洛必德科技有限公司签订了增资协议，支付投资款人民币1000万元，持股比例1.5365%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630836510","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630836510?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:12","pubTimestamp":1777277533,"startTime":"0","endTime":"0","summary":"证券之星消息，仁和药业(000650)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！公司投资洛必德机器人是几年前的事了，证明公司的长远发展眼光非常独到，如果洛必德上市，公司就是直接受益者仁和药业回复：尊敬的投资者您好，公司2021年6月，与北京洛必德科技有限公司签订了增资协议，支付投资款人民币1000万元，持股比例1.5365%。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700027995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["UCmain","BK0188","000650","CYB","MUCmain","BK0239","CNHmain","MCNHmain","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630046331","title":"股市必读：仁和药业年报 - 第四季度单季净利润同比下降78.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630046331","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630046331?lang=zh_cn&edition=full","pubTime":"2026-04-27 06:41","pubTimestamp":1777243268,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，仁和药业报收于5.55元，下跌2.8%，换手率1.8%，成交量24.01万手，成交额1.33亿元。股本股东变化股东户数变动近日仁和药业披露，截至2026年4月20日公司股东户数为9.2万户，较3月31日减少2994.0户，减幅为3.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700006756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629814937","title":"仁和药业(000650)4月20日股东户数9.2万户，较上期减少3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629814937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629814937?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:32","pubTimestamp":1777023154,"startTime":"0","endTime":"0","summary":"证券之星消息，近日仁和药业披露，截至2026年4月20日公司股东户数为9.2万户，较3月31日减少2994.0户，减幅为3.15%。在中药行业个股中，仁和药业股东户数高于行业平均水平，截至4月20日，中药行业平均股东户数为5.31万户。从股价来看，2026年3月31日至2026年4月20日，仁和药业区间涨幅为0.52%，在此期间股东户数减少2994.0户，减幅为3.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400052720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780219325608,"stockEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":-0.0614},{"period":"3month","weight":-0.1113},{"period":"6month","weight":-0.1039},{"period":"1year","weight":-0.0041},{"period":"ytd","weight":-0.0531}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0095},{"period":"3month","weight":-0.0227},{"period":"6month","weight":0.0463},{"period":"1year","weight":0.2096},{"period":"ytd","weight":0.0251}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"仁和药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"92000人(较上一季度减少3.15%)","perCapita":"14471股","listingDate":"1996-12-10","address":"江西省宜春市樟树市葛玄路6号","registeredCapital":"139993万元","survey":" 仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是口服固体制剂、口服液体制剂、大容量注射剂、小容量注射剂、外用洗剂、搽剂、栓剂、软膏剂、健康相关产品。","listedPrice":6.26},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仁和药业,000650,仁和药业股票,仁和药业股票老虎,仁和药业股票老虎国际,仁和药业行情,仁和药业股票行情,仁和药业股价,仁和药业股市,仁和药业股票价格,仁和药业股票交易,仁和药业股票购买,仁和药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}